Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10635216 | 1.00 | LMNA (0.50) | LMNANPC1RAB9AALDH1A1CA2 | |
| Hydrogen Peroxide SCHEMBL8672190 | 0.90 | BCL2L1 (0.46) | LMNANPC1RAB9AALDH1A1CA2 | |
| Hydrogen Peroxide SCHEMBL8672187 | 0.90 | BCL2L1 (0.46) | LMNANPC1RAB9AALDH1A1CA2 | |
| SCHEMBL9927352 | 0.89 | CES2 (0.39) | LMNANPC1RAB9AALDH1A1CA2 | |
| SCHEMBL779999 | 0.89 | CES2 (0.39) | LMNANPC1RAB9AALDH1A1CA2 | |
| SCHEMBL19010398 | 0.89 | ACHE (0.52) | LMNANPC1RAB9AALDH1A1MEN1 | |
| SCHEMBL132983 | 0.87 | LMNA (0.60) | LMNAALDH1A1CA2CA4CA5A | |
| SCHEMBL5436616 | 0.87 | LMNA (0.60) | LMNAALDH1A1CA2CA4CA5A | |
| SCHEMBL5439069 | 0.87 | LMNA (0.60) | LMNAALDH1A1CA2CA4CA5A | |
| SCHEMBL4791094 | 0.86 | MEN1 (0.50) | LMNANPC1RAB9AALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12615908-B2 | Wide bandgap perovskite quantum dots in a perovskite matrix and process for preparing same | Huawei Technologies Canada Co., Ltd. (CA) | 2026-04-28 | — | — | US | claimed |
| CN-119285931-A | Preparation method of polyarylether phosphine oxide intrinsic type room temperature phosphorescent material | 重庆理工大学 | 2025-01-10 | — | — | CN | claimed |
| CN-114702949-B | Perovskite quantum dot-polymer composite film and preparation method thereof | 中国矿业大学 | 2024-02-27 | — | — | CN | claimed |
| CN-113336936-B | Sulfonated aromatic phosphine oxide polymer containing bisphenol fluorene, and preparation method and application thereof | 上海应用技术大学 | 2023-08-29 | — | — | CN | claimed |
| WO-2023087117-A1 | WIDE BANDGAP PEROVSKITE QUANTUM DOTS IN A PEROVSKITE MATRIX AND PROCESS FOR PREPARING SAME | Huawei Technologies Canada Co., Ltd. (CA) | 2023-05-25 | — | — | WO | claimed |
| US-20230165129-A1 | WIDE BANDGAP PEROVSKITE QUANTUM DOTS IN A PEROVSKITE MATRIX AND PROCESS FOR PREPARING SAME | Huawei Technologies Canada Co., Ltd. (CA) | 2023-05-25 | — | — | US | claimed |
| CN-115819258-A | Preparation method of sitagliptin intermediate by using phosphine-oxygen double bond-containing catalyst | 浙江大学 | 2023-03-21 | — | — | CN | claimed |
| CN-114702949-A | Perovskite quantum dot-polymer composite film and preparation method thereof | 中国矿业大学 | 2022-07-05 | — | — | CN | claimed |
| CN-108948353-B | Preparation method of atomic oxygen resistant polyimide material | 义乌市诠铈新材料有限公司 | 2020-12-04 | — | — | CN | claimed |
| US-20200131436-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE CHROMOPHORES AND ORGANIC LAYERS INCLUDING THE SAME | WRIGHT STATE UNIVERSITY (US) | 2020-04-30 | — | — | US | claimed |
| US-20080233455-A1 | Proton conductors based on aromatic polyethers and their use as electolytes in high temperature pem fuel cells | ADVENT TECHNOLOGIES SA (GR) | 2008-09-25 | — | — | US | claimed |
| WO-2008090412-A2 | PROTON CONDUCTING AROMATIC POLYETHER POLYMERS WITH PYRIDINYL SIDE CHAINS FOR FUEL CELLS | ADVENT TECHNOLOGIES (GR) | 2008-07-31 | — | — | WO | claimed |
| US-20080160378-A1 | Novel poly(arylene ether) copolymers containing pyridine units as proton exchange membranes | ADVENT TECHNOLOGIES SA (GR) | 2008-07-03 | — | — | US | claimed |
| US-20080113227-A1 | Development and characterization of novel proton conducting aromatic polyether type copolymers bearing main and side chain pyridine groups | ADVENT TECHNOLOGIES | 2008-05-15 | — | — | US | claimed |
| US-20080070093-A1 | Development and characterization of novel proton conducting aromatic polyether type copolymers bearing main and side chain pyridine groups | ADVENT TECHNOLOGIES (GR) | 2008-03-20 | — | — | US | claimed |
| WO-2007084759-A2 | CHLORINE RESISTANT DESALINATION MEMBRANES BASED ON DIRECTLY SULFONATED POLY(ARYLENE ETHER SULFONE) COPOLYMERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-07-26 | — | — | WO | claimed |
| US-20070163951-A1 | Chlorine resistant desalination membranes based on directly sulfonated poly(Arylene Ether Sulfone) copolymers | NAVY, SECRETARY OF THE, UNITED STATES OF AMERICA | 2007-07-19 | — | — | US | claimed |
| WO-2000024818-A1 | CYCLIC OLIGOMER NANOCOMPOSITES | TRITON SYSTEMS, INC. (US) | 2000-05-04 | — | — | WO | claimed |
| US-5691442-A | RADIATION TRANSPARENT POLYMERS WITH PHENOL ENDCAPPING | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1997-11-25 | — | — | US | claimed |
| US-5079333-A | Novel mine-terminated poly(arylene ether phosphine oxide) oligomer | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 1992-01-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070093-A1 | Development and characterization of novel proton conducting aromatic polyether type copolymers bearing main and side chain pyridine groups | PAH, PARG, PAM | LMNA 1525/4885NPC1 4874/4885RAB9A 1959/4885 |
| US-12615908-B2 | Wide bandgap perovskite quantum dots in a perovskite matrix and process for preparing same | KCNQ2, KCNQ1, KCNQ4 | LMNA 2924/4885NPC1 3880/4885RAB9A 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.